Equities

CeCors Inc

CEOS:PKC

CeCors Inc

Actions
  • Price (USD)0.0175
  • Today's Change0.00 / 0.00%
  • Shares traded110.50k
  • 1 Year change-60.23%
  • Beta0.3751
Data delayed at least 15 minutes, as of Jul 02 2024 19:55 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CeCors, Inc. is engaged in the acquisition and development of Emerging Technologies, as well as healthcare and data-related companies. The Company is focused on the health and technology sector, as well as other emerging technologies, primarily on the mental health market through its investment and development of its TeleMed (Telemedicine) Network connecting patients with medical professionals. The Company uses the same network through its CannMedLive, which assists medical cannabis candidates by connecting them with physicians that diagnose and suggest appropriate treatment.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2002
  • Employees6.00
  • Location
    CeCors Inc854 Upper Canada DriveSARNIA N7W 1A4CanadaCAN
  • Phone+1 (480) 659-8036
  • Fax+1 (714) 768-8737
  • Websitehttps://www.cecorsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pasithea Therapeutics Corp0.00-16.10m5.40m8.00--0.2718-----14.03-14.170.0019.060.00----0.00-49.97---53.80--------------0.00-------32.23------
BioCardia Inc468.00k-10.34m5.44m16.00------11.63-7.04-7.040.3132-1.270.0954--4.4429,250.00-210.81-107.34-1,190.90-154.17-----2,208.76-1,779.24---------64.72-5.262.82---28.89--
Tron Pharmaceuticals Inc1.01m-549.47k5.50m50.00------5.45-0.0034-0.00340.0062-0.0508------20,191.00--------60.28---110.51--0.0417-433.32----0.3272---39.70------
Fresh Tracks Therapeutics Inc8.01m-5.69m5.55m4.00--0.5591--0.6934-1.38-1.381.491.660.7326----2,001,500.00-52.10-89.76-66.50-115.24-----71.12-442.61---1,272.000.00--15.3137.6273.02------
Hepion Pharmaceuticals Inc0.00-38.52m5.58m22.00--0.9582-----9.49-9.490.001.370.00----0.00-117.64-61.43-145.05-68.82-----------3,240.310.00-------7.92------
TFF Pharmaceuticals Inc885.71k-19.93m5.61m19.00--0.8596--6.33-10.20-10.200.43712.110.0647--3.7246,616.32-145.46-79.57-181.57-83.41-----2,249.83-8,687.66----0.00--48.01--33.13------
HST Global Inc0.00-141.11k5.72m1.00---------0.0269-0.02690.00-0.11930.00-------29,397.92-5,836.01---------------24.24---------0.7858------
Intelligent Bio Solutions Inc2.83m-10.03m5.74m17.00--0.4816--2.03-64.14-64.144.603.820.20412.697.77166,299.40-72.67-80.65-107.67-224.8423.33---356.09-948.541.87--0.0451--187.51367.97-28.00------
Transcode Therapeutics Inc0.00-17.06m5.75m10.00--1.10-----206.36-206.360.000.78930.00----0.00-264.82-133.14-721.90-181.26-----------148.050.00-------5.59------
Xenetic Biosciences Inc2.44m-4.47m5.77m4.00--0.6648--2.36-2.92-2.921.595.630.2116----611,240.00-38.71-48.91-41.54-52.82-----182.95-682.42----0.00--48.80--36.90------
CeCors Inc-100.00bn-100.00bn5.81m6.00---------------0.0163------------------------------------22.70------
Burzynski Research Institute Inc0.00-1.34m5.83m2.00---------0.0102-0.01020.00-0.00020.00-------62,992.45-15,304.89-------------------------45.74------
NuCana PLC (ADR)0.00-33.94m5.85m25.00--0.4868-----303.31-303.310.005.680.00----0.00-72.34-41.01-125.17-48.07------------0.0324------13.71---21.70--
Ainos Inc93.68k-14.56m5.91m46.00--0.2547--63.06-3.27-3.270.02063.690.00280.81331.622,036.52-43.83-36.36-48.64-58.33-222.1136.82-15,547.49-813.630.2847-75.230.2003---96.539.461.69--66.44--
Cyclerion Therapeutics Inc0.00-10.95m6.11m1.00--0.568-----4.380.29040.003.970.00----0.00-95.95-72.70-158.12-86.96-------2,565.62----0.00---100.00--30.98------
Tenax Therapeutics Inc0.00-10.10m6.23m5.00--0.501-----24.52-24.520.006.350.00----0.00-67.96-199.16-75.66-285.64-----------105.120.0322------30.21------
Data as of Jul 02 2024. Currency figures normalised to CeCors Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.